14/03/2026
Zydus’ new drug discovery, ‘Desidustat’ licensed to China Medical System Holdings receives approval from NMPA of China.
Driven by a passion for innovation, making a difference in the world of healthcare. The group aspires to transform lives through pathbreaking discoveries.
Zydus Corporate Park
Ahmedabad
Be the first to know and let us send you an email when Zydus Lifesciences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.